Differences in Pain Processing Between Men and Women

NCT ID: NCT05031286

Last Updated: 2023-04-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

66 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-05-01

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Many chronic pain conditions show clear differences between between men and women, such as reported pain intensities or treatment effects, with chronic pain conditions being generally more frequent in women. Yet, the underlying mechanisms causing these differences are poorly understood. Central sensitization (CS) is considered one important mechanism in pain patients which differs between female and male patients. The central hypothesis is that already in the healthy population CS processes are more pronounced in women than in men.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Central Sensitisation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental Arm

Group Type EXPERIMENTAL

Cutaneous thermal stimuli

Intervention Type OTHER

Application of thermal stimuli of different intensities to the skin

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cutaneous thermal stimuli

Application of thermal stimuli of different intensities to the skin

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* good general health
* able to give informed consent

Exclusion Criteria

* pain complaints for more than two consecutive days over the past three months
* any major medical or psychiatric condition (e.g. heart disease, major depressive disorder)
* any chronic pain condition
* inability to follow study instructions
* consumption of stimulants, drugs, or analgesics within the past 24 hours
* scar tissue or generally reduced sensitivity in the designated testing site areas
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Balgrist University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Schweinhardt Petra

Head of Research at the Department of Chiropractic Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Petra Schweinhardt, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Department of Chiropractic Medicine, Balgrist University Hospital, University of Zurich

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Balgrist Campus

Zurich, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

References

Explore related publications, articles, or registry entries linked to this study.

Guekos A, Saxer J, Salinas Gallegos D, Schweinhardt P. Healthy women show more experimentally induced central sensitization compared with men. Pain. 2024 Jun 1;165(6):1413-1424. doi: 10.1097/j.pain.0000000000003144. Epub 2024 Jan 11.

Reference Type DERIVED
PMID: 38231588 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NWR

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Gender, Pain, and Placebo Analgesia
NCT00314392 COMPLETED NA